Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
coenzyme Q10 + feverfew + magnesium
- Development stage
- Unknown
- Lead developer
- PiLeJe
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Antemig is a fixed-dose nutraceutical combination containing coenzyme Q10, feverfew (Tanacetum parthenium), and magnesium, developed by PiLeJe for the prophylaxis of migraine in adults. The supplement targets multiple pathophysiological pathways associated with migraines: feverfew contains parthenolide, which inhibits the release of serotonin and pro-inflammatory prostaglandins; coenzyme Q10 acts as an antioxidant and electron carrier to address mitochondrial dysfunction; and magnesium helps correct deficient energy metabolism and neuronal excitability. Clinical evidence suggests that daily supplementation significantly reduces the frequency of migraine attacks, with studies showing a reduction from 4.9 to 1.3 migraine days per month after three months of use.
- Brand names
- Antemig
- Other names
- coenzyme Q10 + feverfew + magnesium
02
Targets
COX-3 (Mitochondrially encoded cytochrome c oxidase subunit 3)ND1 (Mitochondrial electron transport chain complex I)
Beyond the preview
Go deeper on coenzyme Q10 + feverfew + magnesium.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on coenzyme Q10 + feverfew + magnesium.